| 
																	
																	
																		 Connection
 
																		 Laura Dunn to Antineoplastic Agents  
																		
																	 
																		This is a "connection" page, showing publications Laura Dunn has written about Antineoplastic Agents.   
																		
																	 
																			
																					
	
						
				
		
			
			
			|  | 
				
					|  | Connection Strength |  |  
					|  |   |  |  
					|  | 1.464 |  |  |  |  
		
		
			
				Atallah M, Cooper B, Mu?oz RF, Paul SM, Anguera J, Levine JD, Hammer M, Wright F, Chen LM, Melisko M, Conley YP, Miaskowski C, Dunn LB. Psychological Symptoms and Stress Are Associated With Decrements in Attentional Function in Cancer Patients Undergoing Chemotherapy. Cancer Nurs. 2020 Sep/Oct; 43(5):402-410.	
				
				
					Score: 0.380
				
				Lewis KD, Peris K, Sekulic A, Stratigos AJ, Dunn L, Eroglu Z, Chang ALS, Migden MR, Yoo SY, Mohan K, Coates E, Okoye E, Bowler T, Baurain JF, Bechter O, Hauschild A, Butler MO, Hernandez-Aya L, Licitra L, Neves RI, Ruiz ES, Seebach F, Lowy I, Goncalves P, Fury MG. Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors. Ann Oncol. 2024 Feb; 35(2):221-228.	
				
				
					Score: 0.119
				
				Utne I, Cooper BA, Ritchie C, Wong M, Dunn LB, Loyland B, Grov EK, Hammer MJ, Paul SM, Levine JD, Conley YP, Kober KM, Miaskowski C. Co-occurrence of decrements in physical and cognitive function is common in older oncology patients receiving chemotherapy. Eur J Oncol Nurs. 2020 Oct; 48:101823.	
				
				
					Score: 0.094
				
				Jakovljevic K, Kober KM, Block A, Cooper BA, Paul SM, Hammer MJ, Cartwright F, Conley YP, Wright F, Dunn LB, Levine JD, Miaskowski C. Higher Levels of Stress Are Associated With a Significant Symptom Burden in Oncology Outpatients Receiving Chemotherapy. J Pain Symptom Manage. 2021 01; 61(1):24-31.e4.	
				
				
					Score: 0.094
				
				Tejada M, Viele C, Kober KM, Cooper BA, Paul SM, Dunn LB, Hammer MJ, Wright F, Conley YP, Levine JD, Miaskowski C. Identification of subgroups of chemotherapy patients with distinct sleep disturbance profiles and associated co-occurring symptoms. Sleep. 2019 10 09; 42(10).	
				
				
					Score: 0.089
				
				Wright F, Dunn LB, Paul SM, Conley YP, Levine JD, Hammer MJ, Cooper BA, Miaskowski C, Kober KM. Morning Fatigue Severity Profiles in Oncology Outpatients Receiving Chemotherapy. Cancer Nurs. 2019 Sep/Oct; 42(5):355-364.	
				
				
					Score: 0.089
				
				Nolden A, Joseph PV, Kober KM, Cooper BA, Paul SM, Hammer MJ, Dunn LB, Conley YP, Levine JD, Miaskowski C. Co-occurring Gastrointestinal Symptoms Are Associated With Taste Changes in Oncology Patients Receiving Chemotherapy. J Pain Symptom Manage. 2019 11; 58(5):756-765.	
				
				
					Score: 0.088
				
				Ward Sullivan C, Leutwyler H, Dunn LB, Miaskowski C. A review of the literature on symptom clusters in studies that included oncology patients receiving primary or adjuvant chemotherapy. J Clin Nurs. 2018 Feb; 27(3-4):516-545.	
				
				
					Score: 0.078
				
				Miaskowski C, Wong ML, Cooper BA, Mastick J, Paul SM, Possin K, Steinman M, Cataldo J, Dunn LB, Ritchie C. Distinct Physical Function Profiles in Older Adults Receiving Cancer Chemotherapy. J Pain Symptom Manage. 2017 09; 54(3):263-272.	
				
				
					Score: 0.076
				
				Ward Sullivan C, Leutwyler H, Dunn LB, Cooper BA, Paul SM, Conley YP, Levine JD, Miaskowski CA. Differences in symptom clusters identified using symptom occurrence rates versus severity ratings in patients with breast cancer undergoing chemotherapy. Eur J Oncol Nurs. 2017 Jun; 28:122-132.	
				
				
					Score: 0.075
				
				Kober KM, Dunn L, Mastick J, Cooper B, Langford D, Melisko M, Venook A, Chen LM, Wright F, Hammer M, Schmidt BL, Levine J, Miaskowski C, Aouizerat BE. Gene Expression Profiling of Evening Fatigue in Women Undergoing Chemotherapy for Breast Cancer. Biol Res Nurs. 2016 07; 18(4):370-85.	
				
				
					Score: 0.070
				
				Miaskowski C, Cooper BA, Aouizerat B, Melisko M, Chen LM, Dunn L, Hu X, Kober KM, Mastick J, Levine JD, Hammer M, Wright F, Harris J, Armes J, Furlong E, Fox P, Ream E, Maguire R, Kearney N. The symptom phenotype of oncology outpatients remains relatively stable from prior to through 1?week following chemotherapy. Eur J Cancer Care (Engl). 2017 May; 26(3).	
				
				
					Score: 0.069
				
				Kober KM, Cooper BA, Paul SM, Dunn LB, Levine JD, Wright F, Hammer MJ, Mastick J, Venook A, Aouizerat BE, Miaskowski C. Subgroups of chemotherapy patients with distinct morning and evening fatigue trajectories. Support Care Cancer. 2016 Apr; 24(4):1473-85.	
				
				
					Score: 0.067
				
				Cataldo JK, Paul S, Cooper B, Skerman H, Alexander K, Aouizerat B, Blackman V, Merriman J, Dunn L, Ritchie C, Yates P, Miaskowski C. Differences in the symptom experience of older versus younger oncology outpatients: a cross-sectional study. BMC Cancer. 2013 Jan 03; 13:6.	
				
				
					Score: 0.056
				
				Sullivan CW, Leutwyler H, Dunn LB, Cooper BA, Paul SM, Levine JD, Hammer M, Conley YP, Miaskowski CA. Stability of Symptom Clusters in Patients With Breast Cancer Receiving Chemotherapy. J Pain Symptom Manage. 2018 01; 55(1):39-55.	
				
				
					Score: 0.019
				 | 
																	
																		
																			
																					              Connection Strength             
  The connection strength for concepts is the sum of the scores for each matching publication.
 Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
 |